[Results of combined therapy (Adelphan-Esidrix and Ismelin) in severe hypertension].
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012110:Reserpine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D006830:Hydralazine; D012110:Reserpine; D011188:Potassium; D006145:Guanethidine
Ergebnisse einer Kombinationstherapie (Adelphan-Esidrix und Ismelin) bei schwerer Hypertonie.